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Abstract 
Background: Recent reports highlighting the role of particle geometry have suggested that anisotropy can affect 
the rate and the pathway of particle uptake by cells. Therefore, we investigate the internalization by cells of porous 
calcium carbonate particles with different shapes and anisotropies.
Results: We report here on a new method of the synthesis of polyelectrolyte coated calcium carbonate particles 
whose geometry was controlled by varying the mixing speed and time, pH value of the reaction solution, and ratio 
of the interacting salts used for particle formation. Uptake of spherical, cuboidal, ellipsoidal (with two different sizes) 
polyelectrolyte coated calcium carbonate particles was studied in cervical carcinoma cells. Quantitative data were 
obtained from the analysis of confocal laser scanning microscopy images.
Conclusions: Our results indicate that the number of internalized calcium carbonate particles depends on the 
aspect ratio of the particle, whereby elongated particles (higher aspect ratio) are internalized with a higher frequency 
than more spherical particles (lower aspect ratio). The total volume of internalized particles scales with the volume of 
the individual particles, in case equal amount of particles were added per cell.
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Background
A multitude of physicochemical properties of particles 
such as size [1, 2], shape [3–7], charge [8, 9], surface 
chemistry [10–15], the aggregation state and colloidal 
stability [16], as well as stiffness [17, 18] directly influ-
ences their uptake, intracellular trafficking, and even 
exocytosis [19] and cytoskeleton re-organization [20]. 
Different cell types have been used in the experiments 
including macrophages [21, 22]. Furthermore, these 
properties are also known to affect particles’ in  vivo 
circulation, retention, and bio-distribution [23–26]. 
Because these diverse parameters are highly entangled 
[27], experimental determination of the effect of just one 
parameter remains challenging [28]. For example, the 
aggregation state plays a particularly important role as 
it may outweigh the influence of size and charge. On the 
other hand, the formation of the protein corona simul-
taneously affects both the aggregation state of particles 
and their uptake [29]. Therefore, a meaningful analysis 
necessitates that particles appear in the non-aggregated 
state in the medium in which they are applied to cells. In 
case of non-agglomerated particles, the shape of particles 
can also play a substantial role in their interaction with 
cells [30, 31]. While the particle shape alone will most 
likely not determine the pathway by which particles are 
taken up by cells [32], there are studies indicating that the 
shape can significantly affect the kinetics of internaliza-
tion [33]; although in some reports different results have 
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been published [34]. The above conclusions apply to both 
micrometer and nanometer sized particles.
Several studies were conducted to characterize inter-
nalization of non-spherical particles and to compare it to 
spherical particles. For example, polystyrene particles of 
various sizes and shapes were used to study their inter-
nalization by alveolar macrophages [35]. It was found 
that particles of all shapes were taken up by phagocyto-
sis. However, the internalization velocity [36] depended 
on the angle between the particle and the initial contact 
point with the macrophage membrane before internaliza-
tion. This angle determined whether macrophages initiate 
uptake or simply spread on the particles [35]. The influ-
ence of particle orientation on the interaction between 
particles and the plasma membrane has been reported by 
Gilbert et al. [37]. The geometry of the polymer particles 
was found to influence the rate of endocytosis between 
disk-shaped particles and spheres of the same volume. 
Non-spherical particles were reported to have a lower 
uptake than spherical particles [38] attributed to a larger 
curvature radius. Furthermore, disk-shaped “flat” par-
ticles (i.e. oblate spheroid shape with a low aspect ratio) 
were reported to have slower internalization velocity in 
the first hours of incubation with endothelial cells, but 
the accumulation of particles around the nucleus was 
similar to that in the long term [33]. This is consistent 
with the study of Shimoni et  al. who reported that the 
uptake of “flat” polyelectrolyte capsules with decreasing 
aspect ratio (i.e. ratio of height to width) was lower than 
the uptake of spherical capsules with the same composi-
tion [5]. In that study, the fate of the capsules was also 
analyzed, and capsules were reported to be localized in 
lysosomal compartments regardless of their shape. In an 
additional report, Rubner et al. [39] claim that uptake of 
flat particles is slowed down to an extent that the parti-
cles reside as “backpacks” on the cellular plasma mem-
brane. In a different trend, it was reported that HeLa cells 
internalize non-spherical hydrogel particles via several 
different mechanisms, and that they internalize elon-
gated, rod-like particles (i.e. prolate spheroid shape, high 
aspect ratio) at a higher rate [40]. Although this trend 
does not hold for lengthy fibers (i.e. for very large aspect 
ratios); they were found to be internalized at a lower rate 
than that for round particles [41]. Furthermore, Kolhar 
et al. [42] reported similar nonspecific uptake for spheri-
cal and rod shaped particles in brain and lung endothelial 
cells using static cell cultures, microfluidics and in  vivo 
studies in mice. These results were further substantiated 
by a mathematical model. The above mentioned studies 
were conducted under somewhat different conditions, 
which may lead to contradictory results. Data from a 
number of different studies may lead to the general per-
ception that flat particles (i.e. oblate spheroid shape, low 
aspect ratio) are internalized by cells less efficiently than 
spherical ones (i.e. aspect ratio = 1), which, in turn, are 
internalized at a slower rate than particles elongated in 
one dimension (i.e. prolate spheroid shape, high aspect 
ratio) as was presented by Chithrani et al. [1]. However, 
most of these studies suffer from the fact that in addition 
to the shape of particles typically also the size, aggrega-
tion state, and surface chemistry influence their uptake. 
Furthermore, the results depend on the nature of the par-
ticles and type of cells. For example, a recent study made 
a claim opposite to that outlined above: that flat (i.e. two-
dimensionally elongated) as well as rod-like shaped (i.e. 
one-dimensionally elongated) particles are internalized 
faster than spherical ones [43]. This only accentuates the 
need for further studies to create a more comprehen-
sive picture. We note that anisotropy of particles can be 
achieved by synthesizing them with a higher aspect ratio 
(“intrinsic anisotropy”) or simply by controlling their 
patchiness (“extrinsic anisotropy”) [44–46]. Anisotropic 
particles adsorb and orient themselves differently even at 
the border of two different media [47].
In our present work we fabricated anisotropic, polye-
lectrolyte-coated porous calcium carbonate micropar-
ticles (CaCO3) of different shapes and different aspect 
ratios. These particles were used to investigate the impact 
of shape on the particle internalization by cervical car-
cinoma cells. Porous CaCO3 microparticles [48, 49] are 
attractive because of their acceptable biocompatibility, 
high surface area to volume ratio, high loading capacity 
for cargo molecules [50], and low synthesis costs. These 
particles serve the function of versatile templates for the 
assembly of hollow polyelectrolyte microcapsules [51–
55]. The capsules, fabricated on various templates [56], 
may be either spontaneously internalized by cells [32, 
57–59], or specifically targeted to cells [60]. The poros-
ity of CaCO3, which is often used as a template or core 
for capsules [48, 56], is one of the key features regard-
ing their application in drug delivery [61], and it has 
been employed for entrapping dyes, polymers, proteins, 
polypeptides, inorganic nanoparticles, etc. into the inner 
volume for sensor applications [62], enzyme-catalyzed 
reactions [63, 64] or intracellular uptake of capsules [65–
68] by cells. In a commonly used preparation method of 
such particles equal amounts of salt concentrations are 
mixed producing spherical particles.
In this work we have prepared three different shapes: 
porous spherical, ellipsoidal, and cuboidal particles [69], 
using a new method in which unequal concentrations of 
the interacting salts were used, and compare them with 
porous spherical calcium carbonate as well as commer-
cially available smooth silica particles serving as con-
trol. The particles were coated with polyelectrolytes, so 
that the surface charges are adjusted, while on the other 
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hand this coating could allow constructing capsules with 
the possibility of controlled release [70–74]. During the 
course of our work, we have also varied the sizes [75] of 
calcium carbonate particles using yet another innova-
tive approach, in which ethylene glycol was used to slow 
down the course of the reaction, thus providing data on 
the influence of the size of particles on their uptake by 
cells.
Results and discussion
In order to obtain calcium carbonate particles of different 
shapes, cf. Fig. 1, several parameters were adjusted during 
their synthesis: the stirring time ts, the presence/absence 
of ethylene glycol in the aqueous solution in which 
CaCl2 and Na2CO3 were mixed, the sodium carbonate 
to calcium chloride ratio S, and the pH of the CaCl2 and 
Na2CO3 solutions. By adjusting the stirring time (and to 
a little extent also the pH of the CaCl2 and Na2CO3 solu-
tions), while keeping the concentrations of CaCl2 and 
Na2CO3 equal, we were able to fabricate spherical parti-
cles of different sizes (Fig.  2a). The solubility of CaCO3 
particles increases by decreasing the pH [76, 77]. At 
pH = 5 the solubility of CaCO3 particles reaches a critical 
point, and, if they are stirred at this pH for longer than 
Fig. 1 The first row from the top: schematics of the geometry of the investigated particles. a “Small” spherical CaCO3 particles, b “small” ellipsoidal 
CaCO3 particles, c cuboidal CaCO3 particles, d “big” ellipsoidal CaCO3 particles, and e control “big” spherical SiO2 particles. All particles have sym‑
metry in the x–y plane. d1 describes the extension of the particles along the axis of symmetry, and d2 the extension perpendicular to this axis. The 
second row from the top: fluorescence microscopy images of the different particles used in the uptake study as recorded in solution for (a) through 
(e). The scale bars in all images correspond to 20 µm. The third row from the top: SEM images of the different particles used in the uptake study 
for (a) through (e). The scale bars in all images correspond to 2 μm. The fourth row from the top: TEM images of the different particles used in the 
uptake study for (a) through (e). The scale bars in all images correspond to 1 μm.
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2 min, they completely dissolve. Thus, at low pH the size 
of CaCO3 particles cannot be modified by controlling the 
stirring time for longer than 2 min, cf. Fig. 2a. Contrary, 
at higher pH values the size can be better controlled by 
altering the stirring time. Figure 2a shows the influence 
of the stirring time obtained with different salt solution 
pHs (5, 7, 9) when mixing 1  mL of each Na2CO3 and 
CaCl2 (both 0.33 M, i.e. S = 1). The size of the particles 
decreased when the stirring time was increased, in agree-
ment with the results reported by Sawada et al. [78]. The 
decrease of particle size was explained by these authors 
by assuming a phase transition from the unstable vater-
ite to the stable calcite. This transformation is due to the 
higher solubility of vaterite compared to calcite. There-
fore, the phase transition is energetically favorable [78]. 
Increasing the pH value from 7 to 9 further decreases the 
particle size to only a little extent, cf. Fig. 2a.
Anisotropic growth could be also achieved by varying 
the composition of the solvent, e.g. by using mixtures of 
ethyleneglycol (EG) and water. The presence of EG in the 
reaction solution decreases the calcium carbonate solu-
bility [75] and changes the time of the reaction between 
CaCl2 and Na2CO3 from minutes to hours. We found 
that, after the first 30 s of stirring, the lengths of the long-
est axis of the particles d1 were around 3 and 6 μm, at salt 
ratios S = 2.5 and S = 10, respectively (Fig. 2b). Extend-
ing the mixing time to 10 min resulted in the formation 
of particles with d1  ≈  2  μm regardless of salt concen-
tration ratio. The size of the particles slightly decreased 
to approximately d1 ≈  1 μm upon further stirring. The 
shape, however, can be also modified in the absence of 
EG by increasing the salt concentration ratio and the 
stirring time. Figure 2c shows the change of aspect ratio 
R = d1/d2 at different salt concentrations S, two different 
stirring times ts, and presence/absence of EG. Overall 
this approach enables the control of the CaCO3 parti-
cle size with d1 between 0.5 and 6 μm with aspect ratios 
ranging from 1 to 2. The synthesis of cuboidally shaped 
particles requires extended time, i.e. stirring, for at least 
3  h, in water. Table  1 gives a summary of the obtained 
CaCO3 particle geometries and of the commercial SiO2 
particles used for the cellular uptake study. We note that 
although a direct comparison between smooth silica and 
porous calcium carbonate particles is difficult, the influ-
ence of the porosity could be assessed. Inherent mono-
dispersity of silica particles would be an additional factor 
in this assessment.
The number of internalized particles per cell was evalu-
ated after 24 h incubation by counting the particles inside 
HeLa cells via fluorescence microscopy and subsequent 
image analysis. A 24-h-incubation period was chosen 
because different endocytic processes proceed with 
different kinetics (e.g. clathrin-mediated endocytosis 
Fig. 2 Tuning the sizes of particles. a The size d = d1 = d2 of spherical CaCO3 particles was tuned by varying the stirring time t of the CaCl2 and 
Na2CO3 solutions at pH values of 5, 7, 9 in pure water solution with a sodium carbonate to calcium chloride ratio S = 1. b The size of the long axis d1 
of ellipsoidal CaCO3 particles was tuned by varying the stirring time ts at certain salt concentration ratios S = 2.5 (black curve); 5 (red curve); and 10 
(blue curve) in water/ethylene glycol = 1/5 solutions of pH = 9.5. c The aspect ratio R (d1/d2) of the CaCO3 particles as a function of S; R was tuned 
by varying the stirring time ts in different water and water/EG (ethylene glycol) mixtures at pH = 9.5. The vertical bars represent the standard devia‑
tion values.
Table 1 Particles with  different shapes and  composed 
of  different materials were used to  study their uptake 
by HeLa cells
The length of the particle extension along the highest symmetry axis d1 (polar 
axis), and the width d2 (equatorial axis) of the particle extension in the plane 
perpendicular to the highest symmetry axis are given, cf. Fig. 1. From d1 and d2 
the particle volume (V) and aspect ratio (R) were calculated. Data represent the 
mean value and standard deviation of 30–50 analyzed particles.
Material Shape d1 (μm) d2 (μm) V (μm
3) R
CaCO3 “Small” spherical 3.3 ± 0.8 3.3 ± 0.8 18.8 1
CaCO3 “Small” ellipsoidal 1.7 ± 0.2 0.9 ± 0.2 0.7 2.0
CaCO3 Cuboidal 2.5 ± 0.9 3.2 ± 1.1 25.6 0.8
CaCO3 “Big” ellipsoidal 3.1 ± 0.5 1.7 ± 0.8 4.7 1.8
SiO2 “Big” spherical 4.8 ± 0.2 4.8 ± 0.2 58.0 1
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proceeds faster than uptake via caveolae). Therefore, a 
long incubation period ensured that the only param-
eter influencing the efficiency of uptake was the particle 
shape and size. The cell cytoskeleton, the nucleus and 
lysosomes were fluorescently stained and the co-localiza-
tion of the red fluorescently labeled microparticles within 
the cellular compartments was evaluated with z-stack 
images as shown in Fig.  3. Figure  4 shows fluorescence 
images of HeLa cells that had internalized the differently 
shaped particles, which are located in the lysosomes, in 
agreement with previous work [32]. Note that multiple 
endocytotic pathways are responsible for particle inter-
nalization [32]. The histograms shown in Fig.  5a and b 
represent the number of cells f(N) which internalized the 
number of N particles and the corresponding cumula-
tive distribution functions (CDFs) p(N) for two sizes of 
ellipsoidal particles. This figure is an example to show 
how the CDFs were calculated for all the samples. In par-
ticular, smaller ellipsoidal particles were internalized in 
higher number compared to bigger particles of similar 
shape. In Fig. 5c the CDFs of “small” spherical, cuboidal, 
“small” and “big” ellipsoidal and control “big” spherical” 
particles are shown, which have been obtained similarly 
to the description of Fig.  5a and b. Cuboidal particles 
were internalized to the lowest degree. Note that these 
cuboidal particles had a similar volume as the spherical 
CaCO3 particles. Thus differences in their internalization 
indicate the influence of the particle shape (assuming 
these are individually dispersed particles). Calcium car-
bonate “small” spherical and “big” ellipsoidal particles, as 
“big” spherical silica particles were taken up by the cells 
to similar extent, even though the silica particles have a 
much larger volume than the CaCO3 particles (58.0 µm3 
for “big” spherical SiO2 compared with 18.8 and 4.7 µm3 
for “small” spherical and “big” ellipsoidal CaCO3, respec-
tively, cf. Table 1). “Small” ellipsoidal particles were inter-
nalized to a much higher extent than all other particles, 
pointing at a correlation between the aspect ratio of par-
ticles and their uptake. The higher the aspect ratio the 
better particles are internalized, which is independent 
of the microparticle size in first order approximation, cf. 
Fig. 5c.
While confirming the influence of particle shape on 
cellular uptake, it is necessary to critically discuss the 
significance of our data. The objective significance is 
limited by several issues. Firstly, as it can be seen from 
Fig.  1 there is some variation in shape (and size) of the 
particles within each batch. Standard particles, such 
as silica spheres used in this study as control are char-
acterized by a very narrow size distribution. The differ-
ently shaped CaCO3 particles as prepared in this study 
were less mono-disperse. Secondly, it is challenging to 
vary only one parameter, such as shape, while keeping 
other parameters, such as size, constant. In the present 
study the main parameter to be varied was the particle 
shape, yet as presented in Table 1 it was accompanied by 
some variations in particle size. Introduction of a scaling 
parameter, the aspect ratio, helped to demonstrate shape-
dependent particle uptake, which in first order was not 
affected by particle size. Thirdly, the physico-chemical 
Fig. 3 Orthogonal view from different planes (x/y, x/z or y/z) of the confocal microscope images used to analyze the particle uptake. Examples cor‑
respond to: a “small” ellipsoidal CaCO3 particles and b “big” spherical SiO2 particles (used as control). Co‑localization of fluorescently labeled CaCO3 
particles (with TRITC, in red) with the lysosomal marker Anti‑LAMP1 labeled with DyLight 649 (artificially colored in yellow). The HeLa cell´s nucleus 
was stained with DAPI (in blue) and the cytoskeleton with Oregon Green® 488 phalloidin (in green). Scale bars correspond to 20 µm.
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properties of the particles may alter significantly once 
they are dispersed in cell media (containing proteins and 
salt). One of the most critical parameters in this context 
is the stability against agglomeration [8, 13]. Obviously 
shape- and size-related effects will be altered if particles 
are no longer individually dispersed, but agglomerated 
[28]. In this study, particles of the same surface chem-
istry, i.e. the same outer polyelectrolyte coating, were 
compared. Thus, while we certainly cannot exclude 
the presence of agglomerates, still the influence of the 
cell medium on the aggregation state of different parti-
cles should be comparable. Fourthly, in case of limited 
Fig. 4 Confocal images of HeLa cells which internalized differently shaped particles (red fluorescence) after incubation for 24 h. a “Small” spherical 
CaCO3 particles, b “small” ellipsoidal CaCO3 particles, c cuboidal CaCO3 particles, d “big” ellipsoidal CaCO3 particles, and e “big” spherical SiO2 particles 
(used as control). Particles are labeled with TRITC (red). Nuclei, lysosomes, and cytoskeletons are fluorescence labeled with DAPI (blue), Anti‑LAMP1 
labeled with DyLight 649 (artificially colored in yellow), and Oregon Green® 488 phalloidin (green), respectively. 1, 2, 3, 4 and 5 mean the red, green, 
blue and yellow channels and the merged image, respectively. The scale bars in all images correspond to 20 μm.
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stability purification is restricted. In Fig. 1 (bottom row) 
for example, some traces of impurities, besides the actual 
particles, can be observed. Taken together these limita-
tions indicate that statements have to be interpreted with 
care. However, our study is in line with several other ones 
wherein the complex influence of shape is pointed out 
[37], i.e. wherein the particle uptake is studied analyzing 
one single parameter—the aspect ratio. Our data confirm 
that flat particles (R  <  1) are incorporated with a lower 
rate than elongated particles (R > 1). To be more precise, 
in case the same amount of particles is added to cells, 
each cell incorporates, on average, a higher number N of 
elongated in comparison with flat particles.
Quantification of particle uptake by cells in terms of 
the number of incorporated particles per cell may not 
always constitute the most appropriate metrics. For 
example, in the case of drug delivery the relevant meas-
ure is the amount of delivered payload or molecular 
cargo. This can be quantified by presenting the delivered 
volume per cell Vt. The larger the volume V of a particle, 
the higher the amount of cargo delivered. The delivered 
volume per cell can be estimated by calculating the num-
ber N of particles internalized per cell multiplied by the 
volume V (cf. Table  1) of each particle (Vt  =  N·V). In 
this way the CDFs can be converted from number dis-
tribution p(N) CDFs into volume distribution p(Vt), cf. 
Additional file  1: Figure S1. The volume distributions 
demonstrate, that in case cells are exposed to the same 
amount of particles (with different particle volumes V), 
the internalized total volume of particles depends on the 
volume of the individual particles, cf. Additional file  1: 
Figure S1. In other words, in case the same amount of 
“small” and “big” microparticles is added to cells, the 
total incorporated volume is higher for the bigger par-
ticles, in first order independent of the aspect ratio of 
the particles. Similar results were obtained when quan-
tifying the delivered surface per cell (Additional file  1: 
Figures S1, S2). The internalized total surface of parti-
cles was higher for larger particles. This indicates that 
the metrics for quantifying particle uptake by cells is of 
Fig. 5 Influence of size on the uptake of ellipsoidal particles by HeLa cells. a Histogram of the frequency f(N) of cells which have internalized N 
particles per HeLa cell after 24 h of particle incubation with a concentration of 10 added particles per cell. b Corresponding cumulative probability 
plot p(N) showing a higher internalization rate for smaller ellipsoidal CaCO3 particles. The vertical bars represent the standard deviation values. c 
Cumulative probability p(N) for N internalized particles per cell for particles with different shape (and size) after 24 h of particle incubation with 
a cocentration of 10 added particles per cell. Cuboidal CaCO3 (black dots), “small” spherical CaCO3 (green dots), “big” spherical SiO2 (pink dots), “big” 
ellipsoidal CaCO3 (red dots), and “small” ellipsoidal (black dots). All particles had the same surface modification (positively charged layer of PAH). The 
vertical bars represent the standard deviation values.
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utmost importance [26], and results will depend on the 
selection of the parameters which are investigated. Upon 
particle uptake (while keeping the number of added 
particles per cell constant) the number of internalized 
particles N scales with the aspect ratio of the particles, 
whereas the total volume of all internalized particles Vt 
depends on the particle volume V.
We note that development of anisotropic particles 
[79–84] and capsules [85–88] is seen to influence the 
transport through the membranes [89], which is signifi-
cant and can be traced even with the ion level precision 
[90], and eventual uptake by cells. Such developments 
are of interest not only for intracellular delivery, but also 
for artificial and multicompartment capsules [91–93]. In 
the present work we only investigated one type of cells, 
one type of surface coating, and one time, and the ani-
sotropy was varied. While the other parameters certainly 
influence particle–cell interaction as analyzed in previous 
studies both experimentally [9, 18, 32] and theoretically 
[36], focus of this work was on analyzing one homolo-
gous study, in which only shape (as related to the volume) 
of the particles was varied.
Conclusions
We have prepared porous calcium carbonate particles 
with different geometries using a novel method con-
trolling physico-chemical parameters such as pH of 
solutions, the ratio of salt concentrations, and the dura-
tion of the reaction. Subsequently, these particles were 
used for studying uptake by living cell. The data shown 
in our study point-out that cellular uptake of particles 
can be related to simple physico-chemical properties of 
the particles. One of the most important aspects in cel-
lular uptake studies, often challenging to implement in 
practice, is to exclusively control the studied parameter. 
In the presented studies, two parameters are varied: the 
aspect ratio of the particles and their sizes, i.e. volumes; 
the influence of these parameters on cell uptake was 
analyzed.
Our results point out that the internalization rate is 
increased with increased aspect ratio (excluding very 
long fibers, wires). If equal amount of particles is added 
per cell, then the total volume of internalized parti-
cles scales with the volume of the individual particles. 
Smooth, monodisperse silica particles were used an addi-
tional control system. The used particle system, porous 
polyelectrolyte multilayer covered calcium carbonate 
particles, offers a number of advantages: inexpensiveness, 
possibility to vary the aspect ratio, porosity, as well as a 
possibility to control such physicochemical properties 
as surface charge and surface chemistry. These advan-
tages make the current system an attractive drug delivery 
platform.
Methods
Materials and methods
For microparticle formation
Poly(allylamine hydrochloride) (PAH, Mw  =  70  kDa), 
poly(sodium 4-styrenesulfonate) sodium salt (PSS, 
Mw  =  70  kDa), tetramethylrhodamine isothiocynate-
dextran (TRITC-dextran, Mw =  70  kDa), calcium chlo-
ride dihydrate (CaCl2·2H2O), and sodium carbonate 
(Na2CO3) were purchased from Sigma-Aldrich, Ger-
many. Ethylene glycol solution (99%) was purchased from 
Alfa Aesar. In all procedures Milli-Q water was used with 
resistivity >18 MΩ.
For cell culture
Trypsin–EDTA was purchased from GIBCO. Dulbecco’s 
Essential Minimum Eagle’s Medium (EMEM), Penicil-
lin–Streptomycin (P/S) was delivered by Sigma-Aldrich. 
Phosphate Buffered Saline (PBS) and fetal serum bovine 
were purchased from Biochrom.
For immunostaining
The primary monoclonal mouse anti-human LAMP1 
antibody was obtained from the Developmental Studies 
Hybridoma Bank. The secondary antibody donkey anti-
mouse IgG (H  +  L) conjugated with DyLight 649 and 
bovine serum albumin (BSA) IgG-free were delivered by 
Jackson Immuno Research Laboratories. (4′,6-diamidino-
2-phenylindol, dilactate) (DAPI) and Oregon Green® 
488 phalloidin were purchased from Life Technolo-
gies. Saponin from quillaja bark (≥10%) was delivered 
by Sigma-Aldrich. Fluoromount-G was obtained from 
SouthernBiotech. Glycine (≥99%) was purchased from 
Roth. A confocal scanning microscope LSM 510 Meta 
(Zeiss), equipped with a diode laser (405  nm; 30 mW), 
an Ar-laser (458, 477, 488,514 nm; 30 mW), a HeNe-laser 
(543 nm; 1 mW), and a HeNe-laser (633 nm; 5 mW) from 
Carl Zeiss was used for the uptake studies. The staining 
protocols used for the uptake studies are explained in 
detail in the Additional file 1 and have been reported pre-
viously by Kast et al. [30].
Synthesis of calcium carbonate particles
Calcium carbonate microparticles of various shapes, 
Fig.  1, were fabricated using a combination of unequal 
salt concentration and addition of ethylene glycol [69] 
while controlling the reaction mixing time and pH 
of the solutions. Briefly, for spherical CaCO3 micro-
particles 1 mL of Na2CO3 (0.33 M, pH 8) was injected 
into a glass vessel and then an equal volume of CaCl2 
(0.33 M, pH 12) was injected and stirred at 600 rpm for 
1 min. This time the pH was not adjusted. Further, the 
diameter of spherical particles was tuned from 3.5 to 
1.5 µm by changing the pH of the salt solutions (CaCl2 
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and Na2CO3), by addition of HCl/NaOH, and the stir-
ring time as it is described in Fig. 2a. Small ellipsoidal 
CaCO3 particles (1.7 ± 0.1 µm) were produced in a mix-
ture of water and ethylene glycol. 1 mL of Na2CO3 (1 M, 
pH  =  9.5) was injected into a glass vessel containing 
10 mL ethylene glycol (EG) under stirring. Then 1 mL of 
CaCl2 (0.1 M, pH = 9.5) was mixed with 10 mL of EG; it 
was subsequently thoroughly stirred and was added to 
the glass vessel containing 1 mL of Na2CO3 and 10 mL 
of EG. The mixture was further stirred at 600  rpm for 
30 min. The pH of the salt solutions was adjusted to 9.5 
by addition of HCl/NaOH. The sodium carbonate to 
calcium chloride concentration ratio, S, was in this case 
equal to 10. The obtained particles had 1.7  ±  0.1  µm 
length for the longest axis (d1), 0.9  ±  0.2  µm for the 
shortest axis (d2) and an aspect ratio R  =  d1/d2  =  2. 
The size of ellipsoidal particles could be also tuned by 
changing the stirring time and by slightly modifying 
the salt concentration ratio, cf. Fig.  1. Large ellipsoidal 
CaCO3 particles were synthesized in water (without 
EG) at conditions identical to that of small ellipsoidal 
particles. Cuboidally shaped particles were prepared by 
mixing 1 mL CaCl2 (1 M, pH 8) and 1 mL Na2CO3 (1 M, 
pH 12) in a glass flask under stirring (without EG). The 
mixture was further stirred at 600 rpm for at least 3 h. 
All particle solutions were thoroughly washed immedi-
ately after the synthesis with water and alcohol in order 
to remove un-reacted components and residual eth-
ylene glycol. Then the particles were placed for 1  h in 
a conventional oven set at 70°C. All differently shaped 
CaCO3 particles were subsequently labeled with fluo-
rescent dextran (TRITC) by entrapping these molecules 
inside the porous CaCO3. To that end the CaCO3 micro-
particles were incubated in 0.5 mL of aqueous TRITC-
dextran solution (1 mg/mL) for 30 min. Then particles 
were washed twice with water. In the final step two 
layers of the synthetic polyelectrolytes poly(allylamine 
hydrochloride) (PAH, 2  mg/mL in 0.5  M NaCl, posi-
tively charged) and poly(sodium 4-styrenesulfonate) 
(PSS, 2 mg/mL in 0.5 M NaCl, negatively charged) were 
adsorbed onto the surface of the CaCO3 particles via the 
layer-by-layer (LbL) technique [51–54]. Since the sur-
face charge of cuboidal particles is almost neutral and in 
order to facilitate polyelectrolyte adsorption they were 
coated first with PSS to produce the following sequence 
of layers: (PSS/PAH/PSS). It should be pointed out that 
the CaCO3 cores were not dissolved at the end of the 
assembly procedure. Commercial, originally negatively 
charged silica particles (4.8  ±  0.2  μm, Microparticles 
GmbH, Germany) were coated with one layer of PAH, 
then incubated with TRITC-dextran and subsequently 
terminated with PSS. This time the fluorescent mol-
ecules labeled the shell of silica particles. Both CaCO3 
and silica particles are terminated with a PSS shell and 
thus were negatively charged at neutral pH.
Characterization of particles
The size of the particles was determined by optical 
microscopy, Fig. 1. The shape of dried particles was con-
firmed by taking scanning electron microscopy (SEM) 
and transmission electron microscopy (TEM) images, 
Fig.  1, the third and fourth row, respectively. The vol-
umes (V) of differently shaped particles were calculated 
using the following formulas. For spherical particles 
V =
4
3
pi
(
d
2
)3
, where d = d1 = d2 is the particle diameter. 
For cuboidal particles V = d1 · d22, assuming “flat” parti-
cles as square base with side lengths d1 and a height of 
d2. For ellipsoidal particles V = 43pi
d1
2
·
(
d2
2
)2
 with the 
diameters d1 of the long axis and d2 of the short axis of 
an ellipsoid with prolate spheroid shape, respectively. All 
particles show symmetry around one axis. The extension 
of the particles along this axis is the particle height d1. 
The extensions of the particles perpendicular to this axis 
are the particle widths d2, cf. Fig.  1. The aspect ratio R 
was calculated as R = d1/d2, e.g. for “flat” particles R < 1, 
for spherical particles R = 1, and for elongated particles 
R > 1.
After the polyelectrolyte layer deposition (last PSS 
layer) the particles had neutral or negative zeta potential. 
For larger spherical particles the value was measured to 
be ~−41.4 ± 0.9 mV, while for small spheres, small ellipse 
and cubes the values were −23.4 ± 0.5, −28.2 ± 0.2 and 
−25.8 ± 0.6, respectively. Zeta-potentials for “big” elliptic 
particles were measured to be close to the neutral value.
Cell experiments
For uptake studies cervical carcinoma HeLa cells 35,000 
cells were seeded for 24 h on sterilized round cover slips 
(Carl Roth) placed on the bottom of 12-well plates with 
18 mm diameter (TTP). Each well was filled with 700 µL 
of Eagle’s Minimum Essential Medium (EMEM), which 
contained 10% vol of fetal bovine serum (FBS), 1% vol of 
the antibiotics penicillin and streptomycin (P/S) at 37°C 
and 5% CO2 atmosphere. After the first 24  h, cells were 
incubated with differently shaped particles with a ratio 
of 10 particles/cell for another 24  h. The concentration 
of particles was calculated with a hemocytometer, which 
was possible due to the large size of the particles that 
allowed for visualization with optical microscopy. After 
that, cover slips were transferred to a flat surface covered 
with parafilm (Carl Roth) to proceed with the fixation of 
the cells and the staining of the cell compartments fol-
lowing several steps. Firstly, cells were fixed with 100 µL 
of a 4% paraformaldehyde solution for 30 min. Then, cells 
were permeabilized with 70 µL of a solution of 0.5  mg/
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mL saponin and 5  mg/mL glycine in phosphate buffered 
saline (PBS) for 5 min. After that, cells were blocked with 
additional 70 µL of 20  mg/mL solution of bovine serum 
albumin (BSA) for 30  min. After blocking the cells were 
incubated for 1  h with primary antibodies LAMP-1 (70 
µL, 1 mg/mL) and washed three times with blocking solu-
tion. Then, cells were incubated for 1 h with (70 µL, 4 mg/
mL) fluorophore-conjugated (DyLight 649) secondary 
antibodies, 4′-6-diamidino-2-phenylindole (DAPI), and 
phalloidin-tetramethylrhodamine. The secondary anti-
bodies labeled with DyLight 649 were used to stain lyso-
somal compartments. DAPI was used to stain the nucleus 
and phalloidin to stain the cytoskeleton. In a last step, 
cells were washed three times with PBS and finally Fluo-
romount-G was used to fix the cover slips above cells on 
glass slides (76 × 26 mm) [24]. Fluorescence micrographs 
of HeLa cells with the internalized particles were recorded 
with a confocal microscope (Zeiss LSM 510 Meta Con-
focal Microscope) equipped with a laser diode emit-
ting at 405  nm (used to visualize the nuclei labeled with 
DAPI, emission filter: LP 420), an argon laser with a line 
at 488 nm (used to visualize the cytoskeleton labeled with 
Oregon Green® 488 phalloidin, emission filter BP 505–
550) and a helium–neon laser for excitation at 543  nm 
(used to visualize the microparticles labeled with TRITC, 
emission filter: BP 560–615) and at 633 nm (used to visu-
alize the lysosomes labeled with DyLight 649, emission 
filter LP 420), respectively. To reduce the scanning time 
we used the same channel and emission filter to visualize 
DAPI and DyLight 649. Lysosomes stained with DyLight 
649 were artificially stained in yellow. Images were taken 
with a Plan-Apochromat 63×/1.40 Oil DIC M27 objec-
tive, and the pin hole was set to 0.86–1.32 airy units. All 
images were recorded and analyzed as z-stacks. The num-
ber of internalized particles per cell was then determined. 
In average, 600–700 particles were counted and at least 
100 different cells were analyzed for every experiment that 
was repeated twice. Dividing and not fully depicted cells 
were not considered for analysis. Taking into account the 
staining of: (1) the actin network which delineated the 
cell shape (green fluorescence coming from fluorescently-
labeled phalloidin), (2) the lysosomal compartments (arti-
ficial yellow color coming from DyLight 649-conjugated 
secondary antibody), and (3) the nucleus inside each cell 
(blue fluorescence coming from DAPI), microparticles 
(in red fluorescently-labeled) surrounded by DyLight 649 
and phalloidin were classified as intracellular. Micropar-
ticles adherent to the outer cell plasma membrane and in 
between the grown cells were clearly distinguished from 
the microparticles with intracellular location, cf. Figs.  3 
and 4 [32]. Based on these confocal images, histograms 
showing the number of internalized particles per cell 
f(N), as well as the corresponding cumulative distribution 
functions (CDFs) p(N) were generated, cf. Fig. 5 and Addi-
tional file 1: Figure S1. Standard deviations were calculated 
from the deviation of the independent f(N) or CDFs of two 
different experiments per each data set. The histogram 
f(N) describes the frequency f, i.e. the number of events, 
in which cells with exactly N internalized particles were 
observed. The CDF p(N) indicates the probability, that a 
cell contains N or less particles internalized. For example, 
p(N = 3) is the probability to find cells with either 0, 1, 2, 
or 3 internalized particles. CDFs are directly calculated 
from histograms where p(N)  = ∑N
i=0
f(i)/
∑
∞
i=0
f(i) and 
they are used to make the differences of particle uptake 
easier to be visualized. The CDFs are normalized and thus 
0 ≤ p(N) ≤ 1 [30]. All data can be found in the Additional 
file 1.
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